SEC Filing Summary: ChromaDex Corporation (8-K)
Business Context and Reporting Period
This Form 8-K Current Report was filed by ChromaDex Corporation on November 6, 2017, regarding events occurring on November 3, 2017. The filing details the entry into a material definitive agreement for a private placement financing.
Key Financial Metrics and Transaction Details
- Financing Amount: $23.0 million in aggregate purchase price.
- Security Type: Common Stock.
- Price Per Share: $4.10.
- Shares to be Issued: 5,609,755 shares.
- Expected Closing Date: November 17, 2017.
- Registration Status: Unregistered (relying on Section 4(a)(2) and Rule 506 of Regulation D).
Material Changes and Agreements
The Company entered into a Securities Purchase Agreement and a Registration Rights Agreement with accredited investors. Under the Registration Rights Agreement, ChromaDex agreed to file registration statements for the resale of the shares. Failure to file or maintain effective registration statements may result in liquidated damages of 1.0% of the aggregate purchase price per month, capped at 5%.
Guidance, Risks, and Contingencies
The closing of the financing is subject to customary conditions, including the absence of a material adverse effect on the Company prior to closing. The filing includes standard forward-looking statements cautioning that actual results may differ due to risks and uncertainties, including those described in the Company's 2016 Form 10-K. No specific operational guidance or revenue outlook was provided in this specific filing.
Investor Verification Checklist
- Verify the actual closing of the transaction on or before November 17, 2017.
- Confirm the issuance of 5,609,755 shares and the receipt of $23.0 million in proceeds.
- Monitor the filing of the registration statement for the resale of shares to ensure compliance with the Registration Rights Agreement.
- Review the full text of the Securities Purchase Agreement (Exhibit 99.1) for specific covenants and conditions.